Press-release for stocks for ABMD

Prices are updated after-hours

Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year
Published: 2021-10-28 (Crawled : 12:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%

| 10.58% | O: -4.23% H: 6.19% C: 3.98%

53%

47%

WISA 4 | $5.33 204.57% 190M

SXTC | $1.78 52.14% 33M

JAGX | $0.178 49.83% 33.26% 600M

DYNT | $0.531 43.36% 30.24% 22M

KA | $0.4796 41.06% 29.11% 5.3M

BSGM | $1.52 38.18% 3.2M

MCBC | $13.67 37.66% 27.36% 2.2M

VIAO | $0.2426 -21.23% 230K

BACK | $4.53 35.22% 26.05% 950K

FNCH | $2.98 32.74% 400K

Save your searches and get alerts when important news are released.